Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,766,960
-
Total 13F shares
-
12,273,522
-
Share change
-
+624,439
-
Total reported value
-
$1,364,432,852
-
Put/Call ratio
-
58%
-
Price per share
-
$111.17
-
Number of holders
-
132
-
Value change
-
+$68,881,092
-
Number of buys
-
63
-
Number of sells
-
51
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q4 2020
As of 31 Dec 2020,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,273,522 shares.
The largest 10 holders included
Capital Research Global Investors, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, HealthCor Management, L.P., VANGUARD GROUP INC, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., and ARMISTICE CAPITAL, LLC.
This page lists
132
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.